These images refer to products that are registered and marketed in Italy.
To this end, Dompé places scientific research at the center of its mission, providing patients with cutting‑edge solutions that support health and respond to the evolving pace of modern life. Among gastrointestinal disorders, gastroesophageal reflux is a highly prevalent condition, responsible for symptoms such as heartburn, acidity, and bloating. Our alginate‑based medical device acts through a mechanical mechanism in the management of gastroesophageal and/or laryngopharyngeal reflux, targeting the full spectrum of reflux‑related symptoms. Products within the Gastro area benefit from deep clinical knowledge and long‑standing trust from physicians, pharmacists, and patients alike, combining Dompé’s historical expertise in these therapeutic fields with a continuous drive toward innovation.
These images refer to products that are registered and marketed in Italy.
Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00 REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153.
This website contains information on products that are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.